Journal of Virology, November 1998, p. 8463-8471, Vol. 72, No. 11
Cell Genesys, Foster City,
California,1 and
Department of Genetics
and Microbiology, University of Geneva Medical School, Geneva,
Switzerland2
Received 1 June 1998/Accepted 21 July 1998
Vectors derived from human immunodeficiency virus (HIV) are highly
efficient vehicles for in vivo gene delivery. However, their
biosafety is of major concern. Here we exploit the complexity of the
HIV genome to provide lentivirus vectors with novel
biosafety features. In addition to the structural genes, HIV contains
two regulatory genes, tat and rev,
that are essential for HIV replication, and four accessory genes that
encode critical virulence factors. We previously reported that the HIV
type 1 accessory open reading frames are dispensable for efficient gene
transduction by a lentivirus vector. We now demonstrate that the
requirement for the tat gene can be offset by placing
constitutive promoters upstream of the vector transcript. Vectors
generated from constructs containing such a chimeric long
terminal repeat (LTR) transduced neurons in vivo at very high
efficiency, whether or not they were produced in the presence of Tat.
When the rev gene was also deleted from the packaging
construct, expression of gag and pol was
strictly dependent on Rev complementation in trans. By the
combined use of a separate nonoverlapping Rev expression plasmid and a
5' LTR chimeric transfer construct, we achieved optimal yields of
vector of high transducing efficiency (up to 107
transducing units [TU]/ml and 104 TU/ng of p24). This
third-generation lentivirus vector uses only a fractional set of HIV
genes: gag, pol, and rev. Moreover,
the HIV-derived constructs, and any recombinant between them, are contingent on upstream elements and trans complementation
for expression and thus are nonfunctional outside of the vector
producer cells. This split-genome, conditional packaging system is
based on existing viral sequences and acts as a built-in device against the generation of productive recombinants. While the actual biosafety of the vector will ultimately be proven in vivo, the improved design
presented here should facilitate testing of lentivirus vectors.
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
A Third-Generation Lentivirus Vector with a
Conditional Packaging System
*
Corresponding author. Mailing address: Cell Genesys,
342 Lakeside Dr., Foster City, CA 94404. Phone: (650) 425-4474. Fax: (650) 358-8636. E-mail: luigin{at}cellgenesys.com.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|